These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3319273)

  • 21. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal cancer induced by N-nitroso compounds.
    Lijinsky W
    Toxicol Pathol; 1988; 16(2):198-204. PubMed ID: 3055229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative carcinogenesis by nitrosomorpholines, nitrosooxazolidines and nitrosotetrahydrooxazine in rats.
    Lijinsky W; Reuber MD
    Carcinogenesis; 1982; 3(8):911-5. PubMed ID: 7127671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinogenesis by nitrosodialkylamines and azoxyalkanes given by gavage to rats and hamsters.
    Lijinsky W; Kovatch RM; Riggs CW
    Cancer Res; 1987 Aug; 47(15):3968-72. PubMed ID: 3607743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkylation of DNA related to organ-specific carcinogenesis by N-nitroso compounds.
    Lijinsky W
    IARC Sci Publ; 1991; (105):305-10. PubMed ID: 1855869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deuterium isotope effects in carcinogenesis by N-nitroso compounds.
    Lijinsky W
    J Cancer Res Clin Oncol; 1986; 112(3):229-39. PubMed ID: 3536943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic and local carcinogenesis by directly acting N-nitroso compounds given to rats by intravesicular administration.
    Lijinsky W; Thomas BJ; Kovatch RM
    Carcinogenesis; 1992 Jul; 13(7):1101-5. PubMed ID: 1638674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogenic effect of subcutaneously administered N-nitroso-2,6-dimethylmorpholine in Syrian golden hamsters.
    Althoff J; Grandjean C; Gold B
    J Natl Cancer Inst; 1978 Jan; 60(1):197-9. PubMed ID: 628016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenicity of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, N-nitrosobis(2-hydroxypropyl)amine and cis-N-nitroso-2,6-dimethylmorpholine administered continuously in the Syrian hamster, and the effect of dietary protein on N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine carcinogenesis.
    Kokkinakis DM; Scarpelli DG
    Carcinogenesis; 1989 Apr; 10(4):699-704. PubMed ID: 2649266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-nitroso-bis(2-acetoxypropyl)amine as a further pancreatic carcinogen in Syrian golden hamsters.
    Pour P; Althoff J; Gingell R; Kupper R; Krüger F; Mohr U
    Cancer Res; 1976 Aug; 36(8):2877-84. PubMed ID: 1277198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenesis in F344 rats by N-nitrosomethyl-n-propylamine derivatives.
    Lijinsky W; Reuber MD; Saavedra JE; Singer GM
    J Natl Cancer Inst; 1983 May; 70(5):959-63. PubMed ID: 6573541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of [3H]thymidine incorporation into DNA of rat esophageal epithelium and related tissues by carcinogenic N-nitroso compounds.
    Mirvish SS; Chu C; Clayson DB
    Cancer Res; 1978 Feb; 38(2):458-66. PubMed ID: 620414
    [No Abstract]   [Full Text] [Related]  

  • 33. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters.
    Pour P; Wallcave L; Gingell R; Nagel D; Lawson T; Salmasi S; Tines S
    Cancer Res; 1979 Oct; 39(10):3828-33. PubMed ID: 225009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenicity of N-nitroso compounds. Species and route differences in regard to organotropism.
    Schmähl D; Habs M
    Oncology; 1980; 37(4):237-42. PubMed ID: 6777721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].
    Druckrey H; Preussmann R; Ivankovic S; Schmähl D
    Z Krebsforsch; 1967; 69(2):103-201. PubMed ID: 4230610
    [No Abstract]   [Full Text] [Related]  

  • 36. Metastasizing tumors in rats treated with alkylating carcinogens.
    Lijinsky W
    Carcinogenesis; 1995 Apr; 16(4):675-81. PubMed ID: 7728942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies with different doses of N-nitrosomorpholine, N-nitrosopiperidine, N-nitrosomethylurea, and dimethylnitrosamine in Syrian golden hamsters.
    Haas H; Mohr U; Krüger FW
    J Natl Cancer Inst; 1973 Oct; 51(4):1295-301. PubMed ID: 4745858
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism of three radiolabeled pancreatic carcinogenic nitrosamines in hamsters and rats.
    Gingell R; Brunk G; Nagel D; Pour P
    Cancer Res; 1979 Nov; 39(11):4579-83. PubMed ID: 227588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study on the carcinogenicity of N-nitroso-2,6-dimethylmorpholine in the European hamster.
    Althoff J; Mohr U; Lijinsky W
    J Cancer Res Clin Oncol; 1985; 109(3):183-7. PubMed ID: 4008512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenicity tests of methyl-n-amylnitrosamine (MNAN) administered to newborn and adult rats and hamsters and adult mice and of 2-oxo-MNAN administered to adult rats.
    Mirvish SS; Nickols J; Weisenburger DD; Smyrk T
    Cancer Lett; 1996 Oct; 107(2):171-7. PubMed ID: 8947509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.